Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
381
-
Total 13F shares, excl. options
-
44.6M
-
Shares change
-
-302K
-
Total reported value, excl. options
-
$6.58B
-
Value change
-
-$39.4M
-
Put/Call ratio
-
0.36
-
Number of buys
-
193
-
Number of sells
-
-167
-
Price
-
$147.54
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2020
438 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q3 2020.
REPLIGEN CORP - COMMON STOCK (RGEN) has 381 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.6M shares
of 56.2M outstanding shares and own 79.34% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.39M shares), VANGUARD GROUP INC (4.25M shares), Invesco Ltd. (2.21M shares), Select Equity Group, L.P. (1.25M shares), Conestoga Capital Advisors, LLC (1.17M shares), FRED ALGER MANAGEMENT, LLC (1.14M shares), STATE STREET CORP (1.14M shares), ALLIANCEBERNSTEIN L.P. (1.13M shares), 12 West Capital Management LP (1.1M shares), and WELLINGTON MANAGEMENT GROUP LLP (989K shares).
This table shows the top 381 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.